BRWA
DNA icon

B. Riley Wealth Advisors’s Ginkgo Bioworks DNA Stock Holding History

B. Riley Wealth Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,433
Closed -$19.2K – 1301
2024
Q2 		$19.2K Sell
1,433
-1,462
-51% -$43.6K ﹤0.01% 1365
2024
Q1 		$210K Sell
2,895
-1,846
-39% -$95.6K 0.01% 1250
2023
Q4 		$321K Buy
4,741
+1,846
+64% +$113K 0.01% 1019
2023
Q3 		$210K Buy
2,895
+1,279
+79% +$102K 0.01% 1250
2023
Q2 		$120K Buy
1,616
+38
+2% +$2.25K ﹤0.01% 1416
2023
Q1 		$84K Sell
1,578
-169
-10% -$10.7K ﹤0.01% 1399
2022
Q4 		$118K Buy
+1,747
New +$161K ﹤0.01% 1340
2021
Q4 		– Sell
-256
Closed -$119K – 1433
2021
Q3 		$119K Buy
+256
New +$125K ﹤0.01% 1316

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

B. Riley Wealth Advisors's DNA Position: Q3 2024 in Review

B. Riley Wealth Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 1,433 shares — an estimated $19.2K sold.

B. Riley Wealth Advisors first reported a position in DNA in Q3 2021 and held it in 8 quarters. The position peaked at $321K in Q4 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • B. Riley Wealth Advisors reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 1,433 Ginkgo Bioworks shares in Q3 2024, an estimated $19.2K.
  • B. Riley Wealth Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 8 quarters.
  • B. Riley Wealth Advisors's Ginkgo Bioworks position peaked at $321K in Q4 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2024, filed 13 Dec 2024.